Effect of antipsychotics on pituitary gland volume in treatment-naive first-episode schizophrenia: A pilot study

被引:52
作者
MacMaster, Frank P.
El-Sheikh, Rhonda
Upadhyaya, Ameet R.
Nutche, Jeffrey
Rosenberg, David R.
Keshavan, Matcheri
机构
[1] Wayne State Univ, Sch Med, Detroit, MI 48201 USA
[2] Univ Pittsburgh, Western Psychiat Inst & Clin, Med Ctr, Pittsburgh, PA 15213 USA
关键词
antipsychotics; magnetic resonance imaging; pituitary; schizophrenia;
D O I
10.1016/j.schres.2007.01.022
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
The objective of this study was to examine the effect of antipsychotics on pituitary volume in schizophrenic subjects. Pituitary volumes were measured in 16 patients with schizophrenia at baseline and 12 months after treatment with an antipsychotic medication using magnetic resonance imaging (MRI). A group of 12 healthy controls was evaluated at baseline and after 12 months. Pituitary volume significantly increased in the schizophrenic subjects after treatment (12% increase). This appeared to be specific to the prolactin-elevating drugs. In controls, pituitary volume did not change significantly (3% decrease). Pituitary volume may be a useful biomarker for treatments that affect neuroendocrine function. (c) 2007 Published by Elsevier B.V.
引用
收藏
页码:207 / 210
页数:4
相关论文
共 17 条
  • [1] ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P789
  • [2] The atypical antipsychotics olanzapine and quetiapine, but not haloperidol, reduce ACTH and cortisol secretion in healthy subjects
    Cohrs, S
    Röher, C
    Jordan, W
    Meier, A
    Huether, G
    Wuttke, W
    Rüther, E
    Rodenbeck, A
    [J]. PSYCHOPHARMACOLOGY, 2006, 185 (01) : 11 - 18
  • [3] Pituitary dimensions and volume measurements in pregnancy and post partum -: MR assessment
    Dinç, H
    Esen, F
    Demirci, A
    Sari, A
    Gümele, HR
    [J]. ACTA RADIOLOGICA, 1998, 39 (01) : 64 - 69
  • [4] First M, 2016, Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P)
  • [5] Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis
    Garner, B
    Pariante, CM
    Wood, SJ
    Velakoulis, D
    Phillips, L
    Soulsby, B
    Brewer, WJ
    Smith, DJ
    Dazzan, P
    Berger, GE
    Yung, AR
    van den Buuse, M
    Murray, R
    McGorry, PD
    Pantelis, C
    [J]. BIOLOGICAL PSYCHIATRY, 2005, 58 (05) : 417 - 423
  • [6] PITUITARY-GLAND GROWTH DURING NORMAL-PREGNANCY - AN INVIVO STUDY USING MAGNETIC-RESONANCE IMAGING
    GONZALEZ, JG
    ELIZONDO, G
    SALDIVAR, D
    NANEZ, H
    TODD, LE
    VILLARREAL, JZ
    [J]. AMERICAN JOURNAL OF MEDICINE, 1988, 85 (02) : 217 - 220
  • [7] Structural MR image processing using the BRAIN2 toolbox
    Magnotta, VA
    Harris, G
    Andreasen, NC
    O'Leary, DA
    Yuh, WTC
    Heckel, D
    [J]. COMPUTERIZED MEDICAL IMAGING AND GRAPHICS, 2002, 26 (04) : 251 - 264
  • [8] Prolactin elevation of the antipsychotic risperidone is predominantly related to its 9-hydroxy metabolite
    Melkersson, Kristina I.
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2006, 21 (08) : 529 - 532
  • [9] OVERALL JE, 1962, PSYCHOL REP, V10, P799
  • [10] Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the Æsop first-onset psychosis study
    Pariante, CM
    Dazzan, P
    Danese, A
    Morgan, KD
    Brudaglio, F
    Morgan, C
    Fearon, P
    Orr, K
    Hutchinson, G
    Pantelis, C
    Velakoulis, D
    Jones, PB
    Leff, J
    Murray, RM
    [J]. NEUROPSYCHOPHARMACOLOGY, 2005, 30 (10) : 1923 - 1931